CD177 and cancer: Except for the indirect immunomodulatory pathway, the other mechanisms require the direct recognition of and selection between cancerous and normal cells by Lf, possibly involving a primary interaction with peculiar cancer cell surface receptors or a secondary one via the regulation of differential intracellular networks.